XML 36 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Licensed Rights and Other Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2026
Licensed Rights and Other Intangible Assets [Abstract]  
Schedule of License Rights and Other Intangible Assets, Net

The following provides information about our license rights and other intangible assets, net as of March 31, 2026 and December 31, 2025 (in thousands):

 

   March 31, 2026   December 31, 2025 
   Gross Carrying
Amount
   Accumulated
Amortization
   Net   Gross Carrying
Amount
   Accumulated
Amortization
   Net 
Intangible assets subject to amortization:                        
Hormone therapy drug patents  $5,695   $2,517   $3,178   $5,695   $2,423   $3,272 
Hormone therapy drug patents applied and pending approval   180    
    180    180    
    180 
Intangible assets subject to amortization   5,875    2,517    3,358    5,875    2,423    3,452 
Intangible assets not subject to amortization:                              
Trademarks/trade name rights   309    
    309    309    
    309 
License rights and other intangible assets, net  $6,184   $2,517   $3,667   $6,184   $2,423   $3,761 
Schedule of Intangible Assets Subject to Amortization

Our intangible assets subject to amortization are expected to be amortized as follows (in thousands):

 

Year ending December 31,
2026  $286 
2027   380 
2028   381 
2029   380 
2030   380 
Thereafter   1,371 
Total  $3,178